Skip to main content

Table 3 List of the miRNAs used to classify patients into R and NR groups

From: Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

Gene name

fold change (R/NR)

T-test

 

Selection by MCCV

   

Rank

appearance frequency in this classification (%)

appearance number of times

hsa-miR-122a

1.50

6.70E-02

1

98.57

690

hsa-miR-21

1.13

5.43E-01

2

89.86

629

hsa-let-7a

1.15

4.23E-01

3

88.71

621

hsa-let-7f

1.24

3.01E-01

4

87.43

612

hsa-miR-148a

1.70

4.51E-02

5

82.71

579

hsa-miR-192

1.24

1.93E-01

6

81.71

572

hsa-miR-126

1.21

3.19E-01

7

74.14

519

hsa-miR-22

1.04

7.88E-01

8

68.43

479

hsa-miR-194

1.20

3.63E-01

9

64.29

450

hsa-miR-23b

1.30

2.06E-01

10

62.00

434

hsa-miR-125b

1.23

2.88E-01

11

61.86

433

hsa-miR-494

0.45

8.17E-02

12

61.14

428

hsa-miR-19b

1.17

3.86E-01

13

61.14

428

hsa-miR-29a

1.11

5.44E-01

14

59.86

419

hsa-miR-26a

1.13

5.38E-01

15

58.43

409

hsa-let-7b

1.01

9.37E-01

16

56.86

398

hsa-miR-142-3p

1.15

5.54E-01

17

52.71

369

hsa-miR-215

1.28

3.93E-01

18

52.00

364

hsa-miR-101

1.31

1.26E-01

19

49.00

343

hsa-miR-451

1.35

5.25E-01

20

48.14

337

hsa-miR-145

0.99

9.76E-01

21

47.14

330

hsa-let-7g

1.15

4.84E-01

22

44.00

308

hsa-miR-29c

1.23

2.94E-01

23

43.71

306

hsa-miR-26b

1.37

2.85E-01

24

43.14

302

hsa-miR-768-3p

1.00

9.91E-01

25

36.29

254

hsa-let-7c

1.16

3.76E-01

26

36.14

253

hsa-miR-370

0.43

7.36E-02

27

35.57

249

hsa-miR-92

1.07

6.65E-01

28

34.14

239

hsa-miR-16

1.11

6.18E-01

29

26.71

187

hsa-miR-29b

1.14

5.19E-01

30

25.71

180

hsa-miR-27b

1.40

1.15E-01

31

25.71

180

hsa-miR-24

1.08

6.56E-01

32

20.57

144

hsa-miR-107

1.00

9.81E-01

33

19.57

137

hsa-miR-143

0.95

7.99E-01

34

18.43

129

hsa-miR-214

0.85

3.61E-01

35

17.86

125